文献速递肿瘤 PET/CT

早期与晚期FAPI-46 PET采集的肿瘤检出等效

Equivalent tumor detection for early and late FAPI-46 PET acquisition.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2021-02-23

该单中心回顾性研究纳入69例癌症患者,比较注射后约10分钟(早期)与约60分钟(晚期)FAPI-46 PET显像。结果显示两组肿瘤病灶检出等效,仅0.5%病灶仅见于早期,最热病灶SUVmax无显著差异;器官本底SUVmean早期至晚期显著下降,病灶SUVmax轻微升高。作者建议未来采用早期FAPI-46 PET以改善可行性和扫描流程。

要点

  • 早期(约10分钟)与晚期(约60分钟)FAPI-46 PET的肿瘤病灶检出等效。
  • 最热肿瘤病灶SUVmax在早期与晚期之间无显著差异(P=0.73)。
  • 器官本底SUVmean早期至晚期显著下降,病灶SUVmax轻微升高。

核心结论

  • 早期(约10分钟)与晚期(约60分钟)FAPI-46 PET显像产生等效的病灶摄取和肿瘤检出。
  • 为改善可行性和扫描量,作者在未来的临床和研究方案中采用早期FAPI-46 PET。

研究设计与样本

  • 这是一项单中心回顾性研究,在德国Essen大学医院进行。
  • 共纳入69例因癌症再分期(n=52,75%)或分期(n=17,25%)接受双时间点显像的患者。
  • 患者接受两次PET采集:早期(平均11分钟,SD 4)和晚期(平均66分钟,SD 9)。
  • 平均注射活度为148 MBq(SD 33)。

主要发现

  • 69例患者中共检出400个病灶。
  • 400个病灶中2个(0.5%)仅见于早期显像而未见于晚期显像。
  • 患者水平上,最热肿瘤病灶的SUVmax在早期与晚期之间无显著差异(Wilcoxon检验:P=0.73)。
  • 器官摄取显示SUVmean从早期至晚期显著下降:臀肌平均∆SUVmean为-0.48、肝脏为-0.14、纵隔为-0.27(Wilcoxon检验:P<0.001)。
  • 病灶水平上观察到SUVmax轻微升高(平均∆SUVmax:+0.4,Wilcoxon检验:P=0.03)。

临床怎么用

  • 基于该研究结果,早期(约10分钟)FAPI-46 PET可替代晚期显像用于肿瘤检出,有利于改善检查可行性和扫描流程。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Positron emission tomography (PET) using small ligands of the fibroblast activation protein (FAP) was recently introduced. However, optimal uptake time has not been defined yet. Here, we systematically compare early (~ 10 min p.i.) and late (~ 60 min p.i.) FAPI-46 imaging in patients with various types of cancer. METHODS: This is a retrospective single-institutional study. Imaging was performed at the Essen University Hospital, Germany. A total of 69 patients who underwent dual time-point imaging for either restaging (n = 52, 75%) or staging (n = 17, 25%) of cancer were included. Patients underwent PET with two acquisitions: early (mean 11 min, SD 4) and late (mean 66 min, SD 9). Mean injected activity was 148 MBq (SD 33). RESULTS: In total, 400 lesions were detected in 69 patients. Two of 400 (0.5%) lesions were only seen in early time-point imaging but not in late time-point imaging. On a per-patient level, there was no significant difference between SUVmax of hottest tumor lesions (Wilcoxon: P = 0.73). Organ uptake demonstrated significant early to late decrease in SUVmean (average ∆SUVmean: - 0.48, - 0.14, - 0.27 for gluteus, liver, and mediastinum, respectively; Wilcoxon: P < 0.001). On a per-lesion basis, a slight increase of SUVmax was observed (average ∆SUVmax: + 0.4, Wilcoxon: P = 0.03). CONCLUSION: In conclusion, early (~ 10 min p.i.) versus late (~ 60 min p.i.) FAPI-46 imaging resulted in equivalent lesion uptake and tumor detection. For improved feasibility and scan volume, we implement early FAPI-46 PET in future clinical and research protocols.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Ferdinandus J, Kessler L, Hirmas N, et al. Equivalent tumor detection for early and late FAPI-46 PET acquisition. Eur J Nucl Med Mol Imaging. 2021. PMID: 33620560. doi:10.1007/s00259-021-05266-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。